The economic impacts of using adalimumab (Humira((R))) for reducing pain in people with ankylosing spondylitis: A microsimulation study for Australia

Schofield, D; Shrestha, R; Cunich, M

Cunich, M (reprint author), Univ Sydney, Charles Perkins Ctr, Fac Pharm, Hlth Econ, Sydney, NSW 2006, Australia.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018; 21 (5): 1106

Abstract

AimThe onset and progression of ankylosing spondylitis (AS) usually occurs during the life stage when individuals are more likely to be working and re......

Full Text Link